用可溶性竞争剂阻断CD28/B7：mCTLA4-Hγ1转基因小鼠的免疫表型 - Suppr

Suppr

超能文献

Blocking CD28/B7 with soluble competitors: immunological phenotype of mCTLA4-H gamma 1 transgenic mice.

作者信息

Lane P

机构信息

Basel Institute for Immunology, Switzerland.

出版信息

Res Immunol. 1995 Mar-Apr;146(3):176-9. doi: 10.1016/0923-2494(96)80254-9.

DOI:10.1016/0923-2494(96)80254-9

PMID:8525050

Abstract

摘要

相似文献

Blocking CD28/B7 with soluble competitors: immunological phenotype of mCTLA4-H gamma 1 transgenic mice.

Res Immunol. 1995 Mar-Apr;146(3):176-9. doi: 10.1016/0923-2494(96)80254-9.

CD28/CTLA-4 receptor structure, binding stoichiometry and aggregation during T-cell activation.

Res Immunol. 1995 Mar-Apr;146(3):130-40. doi: 10.1016/0923-2494(96)80246-x.

CTLA-4 and T cell activation.

Curr Opin Immunol. 1999 Jun;11(3):294-300. doi: 10.1016/s0952-7915(99)80047-8.

The complexities of T-cell co-stimulation: CD28 and beyond.

Immunol Rev. 1996 Oct;153:155-82. doi: 10.1111/j.1600-065x.1996.tb00924.x.

CD80 (B7-1) and CD86 (B7-2): potential targets for immunotherapy?

Res Immunol. 1995 Mar-Apr;146(3):183-96. doi: 10.1016/0923-2494(96)80256-2.

Treatment of autoimmunity by inhibition of T cell costimulation.

Adv Exp Med Biol. 2001;490:113-7. doi: 10.1007/978-1-4615-1243-1_12.

B7-CTLA4 interaction promotes cognate destruction of tumor cells by cytotoxic T lymphocytes in vivo.

Blood. 2002 Apr 15;99(8):2880-9. doi: 10.1182/blood.v99.8.2880.

The role of B7 costimulation in T-cell immunity.

Immunol Cell Biol. 1999 Aug;77(4):304-11. doi: 10.1046/j.1440-1711.1999.00835.x.

Role of B7 signaling in the differentiation of naive CD4+ T cells to effector interleukin-4-producing T helper cells.

Immunol Res. 1995;14(3):176-88. doi: 10.1007/BF02918215.

New protein steals the show as 'costimulator' of T cells.

Science. 1993 Nov 5;262(5135):844-5. doi: 10.1126/science.7694360.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Blocking CD28/B7 with soluble competitors: immunological phenotype of mCTLA4-H gamma 1 transgenic mice.

Res Immunol. 1995 Mar-Apr;146(3):176-9. doi: 10.1016/0923-2494(96)80254-9.

CD28/CTLA-4 receptor structure, binding stoichiometry and aggregation during T-cell activation.

Res Immunol. 1995 Mar-Apr;146(3):130-40. doi: 10.1016/0923-2494(96)80246-x.

CTLA-4 and T cell activation.

Curr Opin Immunol. 1999 Jun;11(3):294-300. doi: 10.1016/s0952-7915(99)80047-8.

The complexities of T-cell co-stimulation: CD28 and beyond.

Immunol Rev. 1996 Oct;153:155-82. doi: 10.1111/j.1600-065x.1996.tb00924.x.

CD80 (B7-1) and CD86 (B7-2): potential targets for immunotherapy?

Res Immunol. 1995 Mar-Apr;146(3):183-96. doi: 10.1016/0923-2494(96)80256-2.

Treatment of autoimmunity by inhibition of T cell costimulation.

Adv Exp Med Biol. 2001;490:113-7. doi: 10.1007/978-1-4615-1243-1_12.

B7-CTLA4 interaction promotes cognate destruction of tumor cells by cytotoxic T lymphocytes in vivo.

Blood. 2002 Apr 15;99(8):2880-9. doi: 10.1182/blood.v99.8.2880.

The role of B7 costimulation in T-cell immunity.

Immunol Cell Biol. 1999 Aug;77(4):304-11. doi: 10.1046/j.1440-1711.1999.00835.x.

Role of B7 signaling in the differentiation of naive CD4+ T cells to effector interleukin-4-producing T helper cells.

Immunol Res. 1995;14(3):176-88. doi: 10.1007/BF02918215.

New protein steals the show as 'costimulator' of T cells.

Science. 1993 Nov 5;262(5135):844-5. doi: 10.1126/science.7694360.